MedPath

LONGAVO

LONGAVO

Approved
DIN Number

02558475

Drug Class

Human

Market Date

N/A

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02558475
AIG Number0067004001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX08 RISPERIDONE
Product Specifications
Dosage FormSuspension (Extended-Release)
Route of AdministrationSubcutaneous
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

RISPERIDONEActive
Strength: 125 MG / 0.35 ML
Monograph: RISPERIDONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.